The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxiety

Pharmacology & Therapeutics
S V ArgyropoulosDavid J Nutt

Abstract

Benzodiazepines have been the mainstay of pharmacological treatment of anxiety over the last 4 decades. The problems associated with their use prompted the research for alternative agents that would be useful in anxiety conditions. Old classes of antidepressants, such as tricyclic antidepressants and monoamine oxidase inhibitors, showed effectiveness in some anxiety syndromes, even in areas where benzodiazepines were not very effective. Newer antidepressants, the selective serotonin-reuptake inhibitors, also appear very useful in some anxiety states, and their favourable side-effect profile has elevated them to first-line treatment tools in these conditions. However, the ideal anxiolytic does not exist. Research with other new compounds is very active, and some experimental drugs show promise for the future.

References

Sep 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·C Braestrup, R F Squires
Sep 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·M VersianiR Amrein
Oct 1, 1992·The Journal of Nervous and Mental Disease·W J Livesley, D N Jackson
Nov 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·J VallejoJ M Menchón
Dec 1, 1992·Journal of Clinical Psychopharmacology·W A HewlettW S Agras
Mar 1, 1992·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·I M van VlietH G Westenberg
Jan 1, 1991·Acta Psychiatrica Scandinavica. Supplementum·S AnderschS Rasmussen
Feb 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·J Wardle
Jun 1, 1991·The Journal of Nervous and Mental Disease·T R KostenE L Giller
Feb 1, 1990·Journal of Consulting and Clinical Psychology·J S KloskoJ A Cerny
Feb 1, 1989·Journal of Clinical Psychopharmacology·D J MunjackM Leonard
Sep 1, 1989·The Journal of Nervous and Mental Disease·J D Kinzie, P Leung
Jan 1, 1985·Psychopharmacology·W F SeidelW C Dement
Feb 1, 1987·Journal of Clinical Psychopharmacology·M Lader, D Olajide
Sep 1, 1987·Journal of Affective Disorders·P E Hayes, S C Schulz
May 1, 1988·Psychiatry Research·M ShestatzkyB Lerer
Dec 1, 1986·Psychosomatics·S LipperJ O Cavenar
Mar 1, 1987·Biological Psychiatry·S Goldstein
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·G ChouinardL Annable
May 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·L R HartleyD J Spencer
Apr 1, 1995·Biological Psychiatry·M S KramerS Reines
Jun 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·D M ClarkM Gelder
Dec 1, 1993·Journal of Clinical Psychopharmacology·J R DavidsonW H Wilson
Jun 1, 1993·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S A MontgomeryA J Wood
Aug 1, 1993·Journal of Clinical Psychopharmacology·F R SchneierM R Liebowitz
Apr 1, 1993·Journal of Clinical Psychopharmacology·L M NagyD S Charney
Aug 1, 1996·Journal of Consulting and Clinical Psychology·R B LydiardJ C Ballenger
Jul 8, 1996·Journal of Affective Disorders·M Van AmeringenC Wilson
Jan 1, 1996·Anxiety·Z KaplanJ Levine
Apr 1, 1997·The Journal of Clinical Psychiatry·I M van VlietK L Pian
Jan 1, 1996·Depression and Anxiety·S J PenavaJ F Rosenbaum
May 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J Levine
Jan 1, 1997·The Journal of Clinical Psychiatry·M E Tancer, T W Uhde
Aug 1, 1997·Journal of Clinical Psychopharmacology·R NoyesE H Uhlenhuth
Aug 1, 1997·Journal of Clinical Psychopharmacology·K RickelsC Mercer
Feb 18, 1998·International Clinical Psychopharmacology·J W TillerK Behnke
Apr 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·F R SchneierM R Liebowitz
Apr 29, 1998·Journal of Clinical Psychopharmacology·R L RudolphR Chitra

❮ Previous
Next ❯

Citations

Jan 19, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Nicole R SullivanLouis D Van de Kar
Nov 26, 2003·European Journal of Pharmacology·Alma J GowerYves Lamberty
Jan 22, 2003·Physiology & Behavior·Christiana V A StraussHélio Zangrossi
Apr 15, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daniel J Lodge, Andrew J Lawrence
Jun 12, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Venessa Beijamini, Roberto Andreatini
Nov 26, 2008·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Markus StorvikJari Tiihonen
Apr 1, 2004·Acta Neuropsychiatrica·A C PyleD J Nutt
Jun 24, 2008·Neuropsychiatric Disease and Treatment·Frasia OosthuizenBrian H Harvey
May 16, 2007·Neural Plasticity·Allan V Kalueff
Jun 27, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gabriele GhisleniLisiane O Porciúncula
Aug 22, 2006·Behavioural Brain Research·A EnnaceurP L Chazot
Aug 9, 2005·Neuroscience and Biobehavioral Reviews·A P Carobrez, L J Bertoglio
Sep 20, 2011·Neuroscience·N Albelda, D Joel
Nov 11, 2006·Behavioural Brain Research·Dominique DrapierJean-Michel Reymann
Jul 14, 2010·Arquivos brasileiros de endocrinologia e metabologia·Silvana S FrassettoPatrícia Pereira
Feb 12, 2017·European Journal of Pharmacology·Giuliana Ignácio Teixeira CavalcanteMarta Maria de França Fonteles
May 12, 2016·Inflammatory Bowel Diseases·Gregory ThorkelsonEva Szigethy
Aug 12, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chris S BusseNicholas D P Cosford
Jan 11, 2007·Menopause : the Journal of the North American Menopause Society·Marietta Kaszkin-BettagMarianne Heger
Jul 6, 2006·Amino Acids·K Ebner, N Singewald
Nov 23, 2006·Depression and Anxiety·Allan V Kalueff, David J Nutt
Aug 10, 2010·Behavioural Pharmacology·Plinio C CasarottoFrancisco S Guimarães
Mar 26, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Victoria B RisbroughMark A Geyer
Sep 17, 2013·Basic & Clinical Pharmacology & Toxicology·Raliny O SantosVanessa de Paula Soares-Rachetti
Feb 11, 2011·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Thalita Thais FaustinoRoberto Andreatini
Feb 7, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daphna Joel
May 6, 2009·Pharmacology, Biochemistry, and Behavior·Priscila CagniMarilia Barros
Apr 2, 2019·ACS Chemical Neuroscience·Ronan DepoortèreAdrian Newman-Tancredi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pain Practice : the Official Journal of World Institute of Pain
Kenneth C Jackson
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
M R Lemke
© 2021 Meta ULC. All rights reserved